EpiPen Buyers Can't Appeal Order Yet In Antitrust Case

By Matthew Perlman · October 26, 2021, 4:30 PM EDT

EpiPen buyers can't immediately appeal an order that dismissed racketeering claims from its case accusing Mylan of scheming to inflate the price of the emergency allergy treatment, a Kansas federal judge...

To view the full article, register now.

Documents

Case Information

Case Title

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Case Number

2:17-md-02785

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

August 04, 2017